Skip to content
MedsAcross

Medicine

Xylocaine MPF 0.15 mg/450 mg per 30 mL injection

Epinephrine and Lidocaine · Epidural, infiltration, intracaudal, perineural · Fresenius Kabi
Available on requestPrescription onlyUS FDA

Xylocaine MPF 0.15 mg/450 mg per 30 mL injection is a prescription medicine containing Epinephrine and Lidocaine for epidural, infiltration, intracaudal, perineural use, marketed by Fresenius Kabi, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

All solutions should be stored at 20° to 25°C (68° to 77°F). Protect from light.

Key facts

Active ingredient (INN)
Epinephrine and Lidocaine
Brand
Xylocaine MPF
Strength
0.15 mg/450 mg per 30 mL
Dosage form
Injection
Route
Epidural, infiltration, intracaudal, perineural
Packs
5 vials of 30 mL, 25 vials of 30 mL
Marketing authorisation holder
Fresenius Kabi
Manufacturer
Fresenius Kabi
Origin register
US FDA, United States
Storage
All solutions should be stored at 20° to 25°C (68° to 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 August 2010
Identifiers
RxCUI 1010033, 1010035, 1010671 +7DailyMed set ID ba082c2f-64f4-419d-9c88-74f203316e17NDC 63323-488Application NDA006488

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
5 vial, single-dose in 1 carton / 30 mL in 1 vial, single-dose63323-488-31Fresenius Kabi12 August 2010
25 vial, single-dose in 1 tray / 30 mL in 1 vial, single-dose63323-488-37Fresenius Kabi12 August 2010

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 November 1948Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Epinephrine and Lidocaine

Clinical summary

Epinephrine and Lidocaine is a fixed-dose combination of an amide local anesthetic, an antiarrhythmic and a catecholamine. It is available as injection for infiltration, perineural and submucosal use. MedsAcross supplies Epinephrine and Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Epinephrine and Lidocaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Xylocaine MPF 0.15 mg/450 mg per 30 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.